Pentavalent (DTaP-IPV+Hib) vaccine 2027-2028 (2029, 2030, 2031)
Awarded
The competition has ended and a winner has been selected.
Farmasøytisk engroshandel
The Ministry of Social Affairs and Health has entered into an agreement with Sanofi Oy for the delivery of Pentavalent (DTaP-IPV+Hib) vaccine for the National Immunisation Program in Finland. The contract is for a duration of 1 year during 2027-2028, with three 1-year renewal options, extending the contract until 2031. The estimated quantity for the entire contract period, including renewals, is 560,000 doses, with a total value of 11,088,000 €. The award was based on the lowest price, and two bids were received.
Result
- Winner
- Sanofi Oy
- Number of bids
- 2
- Contract value
- €11,088,000
About the bid
- Contact name
- Hankintayksikkö
- Contact phone
- +358 295246000
- Contact email
- kilpailutus@thl.fi
- Address
- P.O. BOX 33, 00023 Helsinki
This is what we have procured: The Ministry of Social Affairs and Health (later referred to as ”STM”) and the Finnish Institute for Health and Welfare (later referred to as "THL" or “Customer” ) request your tender for Diphtheria, tetanus, acellular pertussis, polio and Haemophilus influenzae type b (DTaP-IPV+Hib) vaccine, required for the vaccinations in the National Immunisation Program in Finland. The contract period is one (1) year during 2027 - 2028. The procurement contains three (3) one (1) -year contract period renewals (1 + 1 + 1) to extend the contract for the years 2029, 2030 and 2031. Estimated quantity for the contract period including contract period renewals is 560,000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The most economically advantageous Tender shall be a Tender with lowest price. Please note that all times given in the Call for Tender refer to local time in Finland. Call for Tenders, annexes: Annex 1 Contract Annex 2 JYSE 2025 SUPPLIES Annex 3 Delivery schedule Annex 4 Subcontractors Annex 5 Description of the Handi Service Annex 6 Bank Details Annex 7 Quality AgreementMain features of the procedureAn open procedure is applied. The procurement will take place in compliance with the Directive 2014/24/EU on public procurement and the Finnish Act on Public Procurement and Concession Contracts (1397/2016). The estimated value of the procurement will exceed the EU threshold value. In case none of the tenders received meets the requirements of the Call for Tender as intended by the Customer, or if conditions change during the procurement process so that the Customer will be unable to make use of the results of the competitive tendering, the Customer may interrupt the procurement procedure. No compensation will be paid to the tenderers for preparing a tender, presenting it or other participations in the procedure. The Call for Tender documents are available in English.
Custom Assessment Criteria
Start a free trial to ask your own questions about the tender and get AI-generated answers.
Award Criteria
Description
The cheapest price
Evaluation Method
The total agreed price is a non-variable sum.
Qualification requirements
Found no qualification requirements in the contract notice.
Previous Contract Winners
Start a free trial to see who has won similar tenders for this buyer.
See the full notice
- Contracting authority
- Ministry of Social Affairs and Health
- Title
- Pentavalent (DTaP-IPV+Hib) vaccine 2027-2028 (2029, 2030, 2031)
- Type
- Main code
- Supplemental codes
- Location
- Helsinki-Uusimaa
- Duration
- 48 months